Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Robots make it to the healthcare conference panel, reflecting the future potential of technology
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Subscribe To Our Newsletter & Stay Updated